首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1575722

全球无针抽血设备市场 - 2024-2031

Global Needle Free Blood Drawing Devices Market - 2024-2031

出版日期: 2024年10月22日 | 出版商:

DataM Intelligence | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

报告概述

2023年，全球无针抽血设备市场规模达到144.3亿美元，预计2031年将达到265.2亿美元，2024-2031年预测期间复合年增长率为7.9%。

无针抽血装置为依赖针头和注射器的传统采血方法提供了无痛替代方案。这些设备将微粒发射到皮肤中，形成一个微小的开口，可以利用负压提取血液。这项创新技术大大减少了患者的不适，并降低了针刺伤的可能性，这是传统采血方法中常见的问题。

无针装置的主要好处在于它们能够减轻抽血相关的疼痛，解决了许多患者的重大问题。这些设备显着降低了医疗保健专业人员被针刺伤的可能性，从而降低了传播血源性病原体的风险。

许多无针设备设计得直观、简单，适合在家庭环境中使用，这可以提高患者对定期健康监测的依从性。这些设备经常利用尖端技术，例如微粒推进或毛细管作用，无需传统针头即可进行血液收集。

市场动态：

司机

无痛替代品的需求不断增加

全球无针采血设备市场的需求受到多种因素的推动。主要因素之一是对无痛替代品的需求不断增加。在美国，人们对无针抽血设备的日益青睐主要是由于对减少痛苦的医疗程序的渴望，特别是对传统针刺方法感到焦虑或不适的患者。这种趋势在进行大量抽血的医院中非常重要，影响临床决策和病患照护。

传统的采血技术，如静脉穿刺，经常给患者带来相当大的疼痛和焦虑。这种不适源于将针插入皮肤和静脉的过程，这对于害怕针的人或需要定期抽血的人来说尤其麻烦。

此外，该行业的主要参与者更加关注有助于推动该市场成长的技术进步。例如，2022 年 4 月，Winnoz Technology 开发的 Haiim 装置透过提供传统静脉穿刺的无针替代方案，代表了血液采集方法的重大进步。这款创新设备旨在从指尖采集血液样本，利用真空辅助技术快速、轻鬆地抽取 150 至 500 微升全血。

此外，2022 年 2 月，Tasso, Inc. 推出了 Tasso Care for Prescreening，这是一项综合服务解决方案，旨在增强临床试验的预筛选流程。该服务旨在利用 Tasso 创新的远端采血技术来简化参与者的招募，该技术以患者为中心并经过临床验证。

限制

设备成本高、设备可用性有限、报销政策有限等因素预计将阻碍市场发展。

细分市场分析

全球无针采血设备市场根据产品类型、技术、最终用户和地区进行细分。

医院细分市场约占全球无针采血设备市场份额的65.6%

预计医院部门将在预测期内占据最大的市场份额。美国每年抽血频率不断增加，刺激了对无针替代品的需求。在医院里，许多患者可能每天需要多次抽血，而由于肥胖、年龄或潜在健康状况而导致静脉通路困难等挑战增加了无针解决方案的必要性。医院在医疗保健产业中发挥着至关重要的作用，影响多达 70% 的临床决策，凸显了有效的采血方法的重要性。

此外，主要参与者的产品发布和批准以及创新技术的发展正在推动该细分市场在该市场的成长。例如，2023 年 11 月，BD (Becton, Dickinson and Company) 在获得美国食品药物管理局 (FDA) 的 510(k) 许可后推出了 PIVO Pro 无针采血设备。这款新设备旨在与整合式导管配合使用，旨在推进 BD 的「单根住院」愿景。

同样，YourBio Health 开发了 HALO 技术，该技术透过使用专利的无刀片微针阵列显着改善血液采集过程，从而实现几乎无痛的抽血。此外，2024年4月，YourBio Health开发的第一代TAP（触摸激活静脉放血）设备代表了采血技术的重大突破。它提供了一种易于使用、几乎无痛的传统抽血替代方案，使其适合临床和远端临床环境。

市场地理分析

北美约占全球无针采血设备市场份额的46.2%

由于对无痛替代品的需求不断增加以及大量抽血将推动美国市场的成长，预计北美地区将在预测期内占据最大的市场份额

此外，FDA等监管机构的批准对于无针采血设备在美国的推广和使用至关重要。能够获得这些批准的公司（例如拥有 PIVO 设备的 BD）将能够在市场上获得竞争优势。在该地区，大量关键参与者的存在、技术进步、先进的医疗基础设施、产品发布和批准以及意识计划、伙伴关係和协作等政府倡议正在推动该市场的成长。

例如，2023 年 12 月，BD (Becton, Dickinson and Company) 的新型 BD MiniDraw 毛细血管采血系统获得了美国食品药物管理局 (FDA) 的 510(k) 许可。这种创新的指尖采血装置旨在透过指尖采血采集血液样本，为传统静脉抽血提供一种侵入性较小的替代方案。该系统允许训练有素的医疗保健专业人员从较小体积的血液中获得实验室质量的结果，使其适用于各种常见的测试。

此外，2022 年 10 月，Catapult Health 和 Tasso 合作，将 Tasso+ 自采样血液采集设备整合到美国大公司和国家健康计画员工的年度医疗保健检查中。此次合作旨在提高常规健康评估期间血液检测的效率和舒适度。

Needle-free blood drawing devices offer a painless alternative to conventional blood collection methods that rely on needles and syringes. These devices launch a micro-particle into the skin, creating a tiny opening that allows blood to be extracted using negative pressure. This innovative technique greatly diminishes patient discomfort and lowers the likelihood of needle-stick injuries, a common issue associated with traditional blood collection methods.

The primary benefit of needle-free devices lies in their capacity to alleviate the pain associated with blood draws, addressing a significant concern for numerous patients. These devices significantly diminish the likelihood of needle-stick injuries among healthcare professionals, thereby reducing the risk of transmitting blood-borne pathogens.

Many needle-free devices are crafted to be intuitive and straightforward, making them suitable for use in home environments, which can improve patient adherence to regular health monitoring. These devices frequently utilize cutting-edge technologies, such as micro-particle propulsion or capillary action, to enable blood collection without the need for traditional needles.

Market Dynamics: Drivers

Increasing demand for pain-free alternatives

The demand for the global needle-free blood drawing devices market is driven by multiple factors. One of the primary factors is the increasing demand for pain-free alternatives. The growing preference for needle-free blood drawing devices in the U.S. is largely driven by the desire for less painful medical procedures, particularly among patients who experience anxiety or discomfort with traditional needle-based methods. This trend is significant in hospitals where a high volume of blood draws occurs, impacting clinical decisions and patient care.

Conventional blood collection techniques, like venipuncture, frequently cause considerable pain and anxiety for patients. This discomfort stems from the process of inserting needles into the skin and veins, which can be especially troubling for individuals who have a fear of needles or for those who need to undergo blood draws regularly.

Moreover, key players in the industry more focus on technological advancements that help to propel this market growth. For instance, in April 2022, the Haiim device, developed by Winnoz Technology, represents a significant advancement in blood collection methods by offering a needle-free alternative to traditional venipuncture. This innovative device is designed to collect blood samples from the fingertips, utilizing vacuum-assisted technology to draw between 150 and 500 microliters of whole blood quickly and less painfully.

Also, in February 2022, Tasso, Inc. launched Tasso Care for Prescreening, a comprehensive service solution designed to enhance the prescreening process for clinical trials. This service aims to streamline the recruitment of participants by utilizing Tasso's innovative remote blood collection technology, which is patient-centric and clinically validated.

Restraints

Factors such as the high cost of devices, limited availability of devices, and limited reimbursement policies are expected to hamper the market.

Market Segment Analysis

The global needle-free blood drawing devices market is segmented based on product type, technology, end-user, and region.

The hospital's segment accounted for approximately 65.6% of the global needle-free blood drawing devices market share

The hospital segment is expected to hold the largest market share over the forecast period. The rising frequency of blood draws conducted each year in the U.S. is fueling the demand for needle-free alternatives. In hospitals, numerous patients may require several blood draws each day, and challenges such as difficult venous access often due to obesity, age, or underlying health conditions are increasing the necessity for needle-free solutions. Hospitals play a vital role in the healthcare industry, affecting as much as 70% of clinical decisions, which underscores the importance of effective blood collection methods.

Moreover, key player's product launches & approvals and innovative technological developments are driving this segment's growth in this market. For instance, in November 2023, BD (Becton, Dickinson and Company) launched the PIVO Pro Needle-free Blood Collection Device after receiving 510(k) clearance from the U.S. Food and Drug Administration (FDA). This new device is designed to work with integrated catheters and aims to advance BD's vision of a "One-Stick Hospital Stay."

Similarly, YourBio Health developed the HALO Technology, created by significantly improving the blood collection process by using a patented bladeless microneedle array, which facilitates nearly painless blood draws. Also, in April 2024, the 1st generation TAP (Touch Activated Phlebotomy) device developed by YourBio Health represented a significant breakthrough in blood collection technology. It offered an easy-to-use, virtually painless alternative to traditional blood draws, making it suitable for clinical and remote clinical settings.

Market Geographical Analysis

North America accounted for approximately 46.2% of the global needle-free blood drawing devices market share

North America region is expected to hold the largest market share over the forecast period owing to the increasing demand for pain-free alternatives and a high volume of blood draws that would propel this market growth in the U.S.

Moreover, Approval from regulatory agencies such as the FDA is crucial for the promotion and utilization of needle-free blood drawing devices in the United States. Companies that can secure these approvals, like BD with its PIVO device, are positioned to gain a competitive advantage in the marketplace. In this region, a major number of key players' presence, technological advancements, well-advanced healthcare infrastructure, product launches & approvals, and government initiatives such as awareness programs, partnerships & collaborations are driving this market growth.

For instance, in December 2023, BD (Becton, Dickinson and Company) received 510(k) clearances from the U.S. Food and Drug Administration (FDA) for its new BD MiniDraw Capillary Blood Collection System. This innovative fingertip blood collection device is designed to collect blood samples through a fingerstick, providing a less invasive alternative to traditional venous blood draws. The system allows trained healthcare professionals to obtain lab-quality results from a smaller volume of blood, making it suitable for various common tests.

Also, in October 2022, Catapult Health and Tasso partnered to integrate the Tasso+ self-sampling blood collection device into annual healthcare checkups for employees at major corporations and national health plans in the USA. This collaboration aims to enhance the efficiency and comfort of blood testing during routine health assessments.

Market Segmentation

By Product Type

Handheld Devices

Wearable Devices

By Technology

Venipuncture

Touch-Based

By End-Users

Hospitals

Ambulatory Surgical Centers

Diagnostic Laboratories

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

The rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the needle-free blood drawing devices market include Becton, Dickinson and Company (BD), YourBio Health, Inc., Tasso, Inc., Romsons, AlphaBiolabs Ltd, Loop Medical SA., Utah Medical Products, Inc., ICU Medical, Inc., and Winnoz Technology, Inc.

Key Developments

In November 2023, BD introduced the PIVO Pro Needle-free Blood Collection Device, which allows blood samples to be drawn directly from a patient's peripheral IV line without using a traditional needle. This innovative device builds upon BD's existing PIVO technology that was first introduced for use with short peripheral IV catheters. The PIVO Pro is designed to be compatible with integrated catheters, including the new Nexiva Closed IV Catheter System with NearPort V Access

In March 2022, Vitestro launched an autonomous blood collection device designed to empower patients by allowing them to participate actively in their blood draw procedures. This innovative venipuncture device utilizes advanced technology, including artificial intelligence and ultrasound-guided imaging, combined with robotic needle insertion, to automate the blood collection process.

Why Purchase the Report?

To visualize the global needle-free blood drawing devices market segmentation based on product type, technology, end-user, and region and understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the needle-free blood drawing devices market with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in excel consisting of key products of all the major players.

The global needle-free blood drawing devices market report would provide approximately 59 tables, 50 figures, and 184 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product type
3.2. Snippet by Technology
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Demand for Pain-Free Alternatives
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Devices
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Handheld Devices *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Wearable Devices

7. By Technology

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 7.1.2. Market Attractiveness Index, By Technology
7.2. Venipuncture *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Touch-Based

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers
8.4. Diagnostic Laboratories
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Becton, Dickinson and Company (BD) *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. YourBio Health, Inc.
11.3. Tasso, Inc.
11.4. Romsons
11.5. AlphaBiolabs Ltd
11.6. Loop Medical SA.
11.7. Utah Medical Products, Inc.
11.8. ICU Medical, Inc.
11.9. Winnoz Technology, Inc. (*LIST NOT EXHAUSTIVE)